Header cover image
  • Investing Ideas
  • /
  • Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies

Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies

Results

36

3 new

Companies with a Value score of at least 3, ordered by Value score

36 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

LUNB

H. Lundbeck		€5.42-3.2%23.5%€38.5b€6.74PE14.9xE8.8%1.7%

ROVI

Laboratorios Farmaceuticos Rovi		€60.45-3.8%4.5%€3.1b€90.59PE19xE18.5%1.8%

IQVH

IQVIA Holdings		€189.80-0.6%-9.0%€35.8b€240.09PE25.5xE13.5%0%

TMOF

Thermo Fisher Scientific		€503.200.5%4.9%€200.4b€625.49PE32.7xE11.5%0.3%

1SXP

SCHOTT Pharma KGaA		€24.341.2%-27.1%€3.7b€32.70PE24.5xE15.7%0.7%

GXI

Gerresheimer		€67.45-10.9%-29.4%€2.3b€112.58PE20.4xE21.8%1.8%

ALM

Almirall		€8.09-3.0%-6.5%€1.7b€11.68PS1.8xE54.5%2.3%

MRCK

Merck KGaA		€138.20-2.2%-2.1%€60.1b€183.75PE22.3xE11.1%1.6%

BAYN

Bayer		€19.02-3.6%-41.6%€18.6b€28.13PS0.4xE55.8%0.6%

VTRS

Viatris		€11.81-2.3%21.7%€14.9b€12.68PS1xE51.6%3.8%

BMYS

Bristol-Myers Squibb		€54.241.7%13.5%€116.3b€57.63PS2.5xE48.7%4.3%

NVAX

Novavax		€8.38-2.6%n/a€1.4b€15.42PS1.6xE67.0%n/a

LUNA

H. Lundbeck		€4.42-2.8%15.1%€38.5b€5.50PE14.9xE8.8%1.7%

IPN

Ipsen		€106.30-2.1%0.3%€8.9b€127.46PE13.4xE6.9%1.1%

GILD

Gilead Sciences		€88.962.2%23.0%€115.4b€95.06PE915.6xE40.7%3.3%

EVT

Evotec		€8.36-3.6%-60.3%€1.5b€10.97PS1.9xE75.5%n/a

REGN

Regeneron Pharmaceuticals		€681.20-2.5%-11.4%€75.5b€1,022.09PE16.2xE6.9%n/a

BIIB

Biogen		€141.35-2.8%-39.5%€21.3b€234.34PE13.2xE13.6%n/a

BAVA

Bavarian Nordic		€25.690.7%8.9%€15.2b€42.55PE13.5xE3.6%n/a

MRK

Merck		€95.20-1.0%-2.9%€248.0b€124.99PE20.4xE16.0%3.3%

ESF

Eurofins Scientific		€47.58-1.4%-18.9%€9.1b€58.99PE27.9xE18.4%1.0%

VLA

Valneva		€1.955.5%-56.8%€312.4m€6.92PS2xE4.6%n/a

SANO

Sanofi		€90.390.6%2.4%€114.4b€112.69PE25.4xE16.8%4.1%

GMAB

Genmab		€196.001.4%-31.4%€92.9b€313.57PE19.8xE23.5%n/a
Page 1 of 2